QUANTITATION OF D SITES ON SELECTED WEAK-D AND PARTIAL-D RED-CELLS

Measurements have been made of the number of available sites on 10 exa mples of red cells in which the only abnormality appeared to be a quan titative reduction in the expression of D (weak D cells); these estima tes were carried out using three monoclonal anti-D antibodies, Fog-1, Brad-3 and Los-2. The values varied with the monoclonal antibody that was used and fell within the range of 170-1,870 sites/cell. A further 3 examples of weak D cells which had brought about immunisation follow ing transfusion were found to have between 390 and 1,470 sites per red cell. The implications of the D site density on the immunogenicity of weak D cells are discussed. The number of sites on red cells with str ucturally abnormal D (partial D cells) were also estimated, using the antibody Fog-1. Four of the 5 examples of cells of category IVa (proba ble phenotype R(o)r) were found to have a high expression of D (range 29,300-41,300), but the available D sites of categories D(Va), D(VIa), and D(VII) were considerably reduced (<500, <500 and 2,400-7,500 site s/cell, respectively). As a working hypothesis, it is suggested that t here are two types of genetic abnormality leading to an abnormal expre ssion of D. First, a defect in genomic DNA leading only to a quantitat ive reduction in the number of available D sites; this genomic lesion should be termed 'weak D'. Secondly, genomic defects leading to amino acid sequence abnormalities and structural change in the D polypeptide ; these lesions should be collectively known as 'partial D'.